Showing results (191-200 of 206) with videos related to
Sort By:
Pageof 21
The Lancet. Oncology|November 22, 2012
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, et al.Nature Reviews. Drug Discovery|April 2, 2011
Managing the challenge of chemically reactive metabolites in drug developmentB Kevin Park, Alan Boobis, Stephen Clarke, et al.JTO Clinical and Research Reports|October 24, 2022
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 StudyQuincy Chu, Natasha B Leighl, Veerle Surmont, et al.Medicines (Basel, Switzerland)|June 13, 2018
Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training InstitutionsByeongsang Oh, Albert Yeung, Penelope Klein, et al.Cancer Immunology, Immunotherapy : CII|April 4, 2023
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumorsJohanna Bendell, Patricia LoRusso, Michael Overman, et al.Nature Medicine|August 15, 2024
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolismJustin Jee, A Rose Brannon, Rohan Singh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket TrialBob T Li, Ronglai Shen, Darren Buonocore, et al.Therapeutic Advances in Medical Oncology|June 28, 2021
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access programOliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, et al.Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.Journal of the National Cancer Institute|December 22, 2017
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram ProjectKatrin M Sjoquist, Lindsay A Renfro, R John Simes, et al.Pageof 21